DE69108262D1 - N-(merkaptoalkyl)amide. - Google Patents
N-(merkaptoalkyl)amide.Info
- Publication number
- DE69108262D1 DE69108262D1 DE69108262T DE69108262T DE69108262D1 DE 69108262 D1 DE69108262 D1 DE 69108262D1 DE 69108262 T DE69108262 T DE 69108262T DE 69108262 T DE69108262 T DE 69108262T DE 69108262 D1 DE69108262 D1 DE 69108262D1
- Authority
- DE
- Germany
- Prior art keywords
- lower alkyl
- aryl
- alkyl
- hydrogen
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/42—Y being a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/633,696 US5232920A (en) | 1990-12-21 | 1990-12-21 | N-(mercaptoalkyl)amides |
PCT/US1991/009189 WO1992011235A1 (en) | 1990-12-21 | 1991-12-19 | N-(mercaptoalkyl)amides |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69108262D1 true DE69108262D1 (de) | 1995-04-20 |
DE69108262T2 DE69108262T2 (de) | 1995-07-06 |
Family
ID=24540737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69108262T Expired - Fee Related DE69108262T2 (de) | 1990-12-21 | 1991-12-19 | N-(merkaptoalkyl)amide. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5232920A (de) |
EP (1) | EP0563153B1 (de) |
JP (1) | JP2511625B2 (de) |
AT (1) | ATE119879T1 (de) |
AU (1) | AU9104691A (de) |
DE (1) | DE69108262T2 (de) |
DK (1) | DK0563153T3 (de) |
ES (1) | ES2072138T3 (de) |
IE (1) | IE73256B1 (de) |
IL (1) | IL100427A0 (de) |
NZ (1) | NZ241063A (de) |
PT (1) | PT99861A (de) |
TW (1) | TW199139B (de) |
WO (1) | WO1992011235A1 (de) |
ZA (1) | ZA9110014B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5177064A (en) * | 1990-07-13 | 1993-01-05 | University Of Florida | Targeted drug delivery via phosphonate derivatives |
US5646276A (en) * | 1992-05-13 | 1997-07-08 | Bristol-Myers Squibb Co. | Diazepine containing dual action inhibitors |
US5552397A (en) * | 1992-05-18 | 1996-09-03 | E. R. Squibb & Sons, Inc. | Substituted azepinone dual inhibitors of angiotensin converting enzyme and neutral exdopeptidase |
US5508272A (en) * | 1993-06-15 | 1996-04-16 | Bristol-Myers Squibb Company | Compounds containing a fused bicycle ring and processes therefor |
US5362727A (en) * | 1993-07-26 | 1994-11-08 | Bristol-Myers Squibb | Substituted azepino[2,1-a]isoquinoline compounds |
US5462964A (en) * | 1993-10-20 | 1995-10-31 | The Du Pont Merck Pharmaceutical Company | Dipeptide boronic acid inhibitors of trypsin-like enzymes |
US5616775A (en) * | 1994-05-05 | 1997-04-01 | Bristol-Myers Squibb Co. | Process for preparing homocystein analogs useful as intermediates for compounds containing a fused bicyclic ring |
US5587375A (en) * | 1995-02-17 | 1996-12-24 | Bristol-Myers Squibb Company | Azepinone compounds useful in the inhibition of ACE and NEP |
US5877313A (en) | 1995-05-17 | 1999-03-02 | Bristol-Myers Squibb | Benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
US5635504A (en) * | 1995-06-07 | 1997-06-03 | Bristol-Myers Squibb Co. | Diazepine containing dual action inhibitors |
US5650408A (en) * | 1995-06-07 | 1997-07-22 | Karanewsky; Donald S. | Thiazolo benzazepine containing dual action inhibitors |
WO2016168090A1 (en) * | 2015-04-14 | 2016-10-20 | Nueon, Inc. | Method and apparatus for determining markers of health by analysis of blood |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4256761A (en) * | 1979-07-13 | 1981-03-17 | Usv Pharmaceutical Corporation | Antihypertensive amides |
US4820729A (en) * | 1981-03-30 | 1989-04-11 | Rorer Pharmaceutical Corporation | N-substituted-amido-amino acids |
US4470973A (en) * | 1982-07-19 | 1984-09-11 | E. R. Squibb & Sons, Inc. | Substituted peptide compounds |
EP0161769B1 (de) * | 1984-04-02 | 1987-10-28 | E.R. Squibb & Sons, Inc. | Enkephalinas-Inhibitoren |
FR2589468B1 (fr) * | 1985-07-30 | 1987-12-31 | Roussel Uclaf | Nouveaux derives du 2-acylamino ethanethiol 2-substitue, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
US4740499A (en) * | 1986-07-28 | 1988-04-26 | Monsanto Company | Method of enhancing the bioactivity of atrial peptides |
-
1990
- 1990-12-21 US US07/633,696 patent/US5232920A/en not_active Expired - Fee Related
-
1991
- 1991-12-19 JP JP4501584A patent/JP2511625B2/ja not_active Expired - Fee Related
- 1991-12-19 PT PT99861A patent/PT99861A/pt not_active Application Discontinuation
- 1991-12-19 AT AT92901485T patent/ATE119879T1/de not_active IP Right Cessation
- 1991-12-19 DK DK92901485.0T patent/DK0563153T3/da active
- 1991-12-19 IL IL100427A patent/IL100427A0/xx unknown
- 1991-12-19 NZ NZ241063A patent/NZ241063A/en unknown
- 1991-12-19 ZA ZA9110014A patent/ZA9110014B/xx unknown
- 1991-12-19 WO PCT/US1991/009189 patent/WO1992011235A1/en active IP Right Grant
- 1991-12-19 AU AU91046/91A patent/AU9104691A/en not_active Abandoned
- 1991-12-19 DE DE69108262T patent/DE69108262T2/de not_active Expired - Fee Related
- 1991-12-19 ES ES92901485T patent/ES2072138T3/es not_active Expired - Lifetime
- 1991-12-19 TW TW080109946A patent/TW199139B/zh active
- 1991-12-19 EP EP92901485A patent/EP0563153B1/de not_active Expired - Lifetime
- 1991-12-20 IE IE448791A patent/IE73256B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NZ241063A (en) | 1995-04-27 |
DE69108262T2 (de) | 1995-07-06 |
JP2511625B2 (ja) | 1996-07-03 |
US5232920A (en) | 1993-08-03 |
ES2072138T3 (es) | 1995-07-01 |
TW199139B (de) | 1993-02-01 |
WO1992011235A1 (en) | 1992-07-09 |
ZA9110014B (en) | 1992-08-26 |
DK0563153T3 (da) | 1995-05-29 |
IL100427A0 (en) | 1992-09-06 |
IE914487A1 (en) | 1992-07-01 |
ATE119879T1 (de) | 1995-04-15 |
IE73256B1 (en) | 1997-05-21 |
EP0563153A1 (de) | 1993-10-06 |
JPH05509331A (ja) | 1993-12-22 |
AU9104691A (en) | 1992-07-22 |
PT99861A (pt) | 1992-12-31 |
EP0563153B1 (de) | 1995-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69108262D1 (de) | N-(merkaptoalkyl)amide. | |
NZ324007A (en) | Quinazoline derivatives susbtituted by a phenyl and medicaments | |
AP1687A (en) | Therapeutic biaryl derivatives. | |
AU7578894A (en) | Methods for inhibiting smooth muscle cell proliferation and restinosis | |
IS1959B (is) | Bensimídazól efnasambönd, lyfjablöndur sem innihalda efnasamböndin og notkun þeirra | |
NZ331613A (en) | Piperazinyl or piperidinyl substituted 1,2,3,4-tetrahydronaphthalene derivatives | |
NZ337967A (en) | 3,3-Diarylpropylamines and their use in the treatment of urinary incontinence | |
NO305174B1 (no) | Heterocykliske forbindelser | |
RU2006106922A (ru) | Амидное производное | |
AU8445591A (en) | N-(mercaptoalkyl)ureas and carbamates | |
ATE365722T1 (de) | 2,4,6-tris(4'aminobenzaldineopentylmalonat)-s- triazin, dieser enthaltenden sonnenschutzzusammensetzungen und dessen verwendungen | |
PE47596A1 (es) | Derivado de quinoxalina util en terapia | |
MXPA03011032A (es) | Activadores de derivados de oxazol/tiazol del receptor hppar-alfa. | |
AP2002002595A0 (en) | Heterocyclic amide derivatives. | |
DE69808326D1 (de) | Azetidinonderivate zur behandlung von hcmv entzündungen | |
ES2055207T3 (es) | Mercapto-acilaminoacidos. | |
AP2001002356A0 (en) | Tricyclic analgesics. | |
EP0372410A3 (de) | Verwendung heterozyklischer Amide zur Verhinderung der Tumormetastasierung | |
DE69916577D1 (de) | Azetidincarboxamid-derivate zur behandlung von zns störungen | |
ATE283269T1 (de) | 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems | |
NZ238154A (en) | Disulphides of 3-mercapto-acylamino acids and pharmaceutical compositions thereof | |
DK1049670T3 (da) | Azetidincarboxamidderivater til behandling af CNS-lidelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |